Characterization of the Cathepsin B Gene and Multiple mRNAs in Human Tissues: Evidence for Alternative Splicing of Cathepsin B Pre-mRNA

DNA and Cell Biology

Volumn 12, Issue 4, 1993, Pages 299-309

  Gong, Qiuming ^a   Chan, Shu Jin ^c   Bajkowski, Andrew S ^a   Steiner, Donald F ^c   Frankfater, Allen ^a,b  

^a Department of Molecular and Cellular Biochemistry ^*  (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; MESSENGER RNA; SIGNAL PEPTIDE;

ARTICLE; BREAST CANCER; COLON CARCINOMA; EXON; GENETIC TRANSCRIPTION; HEP 2 CELL; HUMAN; HUMAN CELL; INTRON; MELANOMA; MOLECULAR CLONING; PRIORITY JOURNAL; RNA SPLICING; RNA TRANSLATION;

ALTERNATIVE SPLICING; BASE SEQUENCE; BLOTTING, NORTHERN; CATHEPSIN B; CLONING, MOLECULAR; DNA; EXONS; HUMAN; INTRONS; KIDNEY; LIVER; MOLECULAR SEQUENCE DATA; RIBONUCLEASES; RNA PRECURSORS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; TRANSLATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0027319177     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.1993.12.299     Document Type: Article

References (53)

1. ACHKAR, C, GONG, Q., FRANKFATER, A., and BAJKOWSKI, A.S. (1990). Differences in targeting and secretion of cathepsin B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts. J. Biol. Chem. 265, 13650-13654.
2. BIACI, A., and KNÖPFEL, M. (1986). Cysteine Proteinases produced by cultured rabbit V2 carcinoma cells and rabbit skin fibroblasts. Int. J. Cancer 38, 753-761.
3. BRAWERMAN, G. (1987). Determinants of messenger RNA stability. Cell 48, 5-6.
4. BREATHNACH, R., and CHAMBON, P. (1981). Organization and expression of eukaryotic split genes coding for proteins. Annu. Rev. Biochem. 50, 349-383.
5. CHAMBERS, A.F., COLELLA, R., DENHARDT, D.T., and WILSON, S.M. (1992). Increased expression of cathepsins B and L and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol. Carcinogen. 5, 238-245.
6. CHAN, S.J., SEGUNDO, B.S., McCORMICK, M.B., and STEINER, D.F. (1986). Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B. Proc. Natl. Acad. Sci. USA 83, 7721-7725.
7. CHIRGWIN, J.M., PRZYBYLA, A.E., MacDONALD, R.J., and RUTTER, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
8. DOCHERTY, K., HUTTON, J.C., and STEINER, D.F. (1984). Cathepsin B-related proteases in insulin secretory granules. J. Biol. Chem. 259, 6041-6044.
9. DOCHERTY, K., and PHILLIPS, I.D. (1988). Molecular forms of cathepsin B in rat thyroid cells (FRTL5): Comparison with molecular forms in liver (HepG2) and insulin-secreting cells (HIT T15). Biochim. Biophys. Acta 964, 168-174.
10. DUFEK, V., MATOUS, B., KRAL, V., and BURES, L. (1984). Characterization of cathepsin B-like proteinase from ascitic fluid of patients with primary liver cancer. Neoplasma 31, 581-590.
11. FERRARA, M., WOJCIK, F., RHAISSI, H., MORDIER, S., ROUX, M.-P., and BÉCHET, D. (1990). Gene structure of mouse cathepsin B. FEBS Lett. 273, 195-199.
12. FROHMAN, M.A., DUSH, M.K., and MARTIN, G.R. (1988). Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85, 8998-9902.
13. GILMAN, M. (1989). In Current Protocols in Molecular Biology, vol. 1. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, eds. (John Wiley and Sons, New York) pp. 4.7.1-4.7.8.
14. HARA, K., KOMINAMI, E., and KATUNUMA, N. (1988). Effect of proteinase inhibitors in intracellular processing of cathepsin B, H, and L in rat macrophages. FEBS Lett. 231, 229-231.
15. HEPLER, J.E., VAN WYK, J., and LUND, P. (1990). Different half-lives of insulin-like growth factor I mRNAs that differ in length of 3′ untranslated sequence. Endocrinology 127, 1550-1552.
16. HIWASA, T., YOKOYAMA, S., HA, J.-M., NOGUCHI, S., and SAKIYAMA, S. (1987). c-Ha-ras gene products are potent inhibitors of cathepsins B and L. FEBS Lett. 211, 23-26.
17. JONES, T.R., and COLE, M.D. (1987). Rapid cytoplasmic turnover of c-myc mRNA: Requirement of the 3′ untranslated sequences. Mol. Cell Biol. 7, 4513-4521.
18. KAWASAKI, E.S. (1990). In PCR Protocols. M.A. Innis, D.H. Gelfand, J.J. Sninsky, and T.J. White, eds. (Academic Press, New York) pp. 21-27.
19. KEPPLER, D., FONDANECHE, M.C., DALET-FUMERON, V., PAGANO, M., and BURTIN, P. (1988). Immunochemical and biochemical study of a cathepsin B-like proteinase in human colonie cancers. Cancer Res. 48, 6855-6862.
20. KEREN, Z., and LeGRUE, S.J. (1988). Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: Modulation by butanol extraction. Cancer Res. 48, 1416-1421.
21. KOPPEL, P., BAICI, A., KEIST, R., MATZKU, S., and KELLER, R. (1984). Cathepsin B-like proteinase as a marker for metastatic tumor cell variants. Exp. Cell Biol. 52, 293-299.
22. KREPELA, E., KASAFIREK, E., NOVAK, K., and VIKLICKY, J. (1990). Increased cathepsin B activity in human lung tumors. Neoplasma 37, 61-70.
23. KRUYS, V., WATHELET, M., POUPART, P., CONTRERAS, R., FIERS, W., CONTENT, J., and HUEZ, G. (1987). The 3′ untranslated region of the human interferon-/3 mRNA has an inhibitory effect on translation. Proc. Natl. Acad. Sci. USA 84, 6030-6034.
24. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
25. LASKEY, R.A. (1980). The use of intensifying screens or organic scintillators for visualizing radioactive molecules resolved by gel electrophoresis. Methods Enzymol. 65, 363-371.
26. LOWE, W.L., JR., ROBERTS, CT., JR., LASKY, S.R., and LeROITH, D. (1987). Differential expression of alternative 5′-untranslated regions in mRNAs encoding rat insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 84, 8946-8950.
27. MACIEWICZ, R.A., WARDALE, R.J., ETHERINGTON, D.J., and PARASKEVA, C. (1989). Immunodetection of cathepsin B and L present in and secreted from human premalignant and malignant colorectal tumour cell lines. Int. J. Cancer 43, 478-486.
28. MITCHELL, P.J., and TJIAN, R. (1989). Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245, 371-378.
29. MOIN, K., ROZHIN, J., McKERNAN, T.B., SANDERS, W.J., FONG, D., HONN, K.V., and SLOANE, B.F. (1989). Enhanced levels of cathepsin B mRNA in urine tumors. FEBS Lett. 244, 61-64.
30. MORT, J.S., RECKLIES, A.D., and POOLE, A.R. (1980). Characterization of a thiol proteinase secreted by malignant human breast tumors. Biochim. Biophys. Acta 614, 134-143.
31. MORT, J.S., LEDUC, M.S., and RECKLIES, A.D. (1983). Characterization of a latent cysteine proteinase from ascitic fluid as a high molecualr weight form of cathepsin B. Biochim. Biophys. Acta 755, 369-375.
32. MURNANE, M.J., SHEAHAN, K., OZDEMIRLI, M., and SHUJA, S. (1991). Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma., Cancer Res. 51, 1137-1142.
33. NISHIMURA, Y., AMANO, J., SATO, H., TSUJI, H., and KATO, K. (1988). Biosynthesis of lysosomal cathepsins B and H in cultured rat hepatocytes. Arch. Biochem. Biophys. 262, 159-270.
34. PAGANO, M., DALET-FUMERON, V., and ENGLER, R. (1988). Purification and characterization of two different precursor forms of the cathepsin B-like proteinase from human malignant ascitic fluid. Biological Chemistry Hoppe-Seyler 369 (Suppl.), 185-190.
35. PAGE, A.E., WARBURTON, M.J., CHAMBERS, T.J., PRINGLE, J.A.S., and HAYMAN, A.R. (1992). Human osteoclastomas contain multiple forms of cathepsin B. Biochim. Biophys. Acta 1116, 57-66.
36. PETROVA-SKALKOVA, D., KREPELA, E., RASNICK, D., and VICAR, J. (1987). A latent form of cathepsin B in pleural effusions. I. Characterization of the enzyme in breast cancer patients. Biochem. Med. Met. Biol. 38, 219-227.
37. PIETRAS, R.J., and ROBERTS, J.A. (1981). Cathepsin B-like enzymes: Subcellular distribution and properties in neoplastic and control cells from human ectocervix. J. Biol. Chem. 256, 8536-8544.
38. QIAN, F., BAJKOWSKI, A.S., STEINER, D.F., CHAN, S.J., and FRANKFATER, A. (1989). Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res. 49, 4870-4875.
39. QIAN, F., FRANKFATER, A., STEINER, D.F., BAJKOWSKI, A.S., and CHAN, S.J. (1991a). Characterization of multiple cathepsin B mRNAs in murine B16 melanoma. Anticancer Res. 11, 1445-1452.
40. QIAN, F., FRANKFATER, A., CHAN, S.J., and STEINER, D.F. (1991b). The structure of the mouse cathepsin B gene and its putative promoter. DNA Cell Biol. 10, 159-268.
41. QIAN, F., CHAN, S.J., GONG, Q., BAJKOWSKI, A.S., STEINER, D.F., and FRANKFATER, A. (1991c). The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors. Biomed. Biochim. Acta 50, 531-540.
42. RECKLIES, A.D., TILTMAN, K.J., STOKER, T.A.M., and POOLE, A.R. (1980). Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res. 40, 550-556.
43. RECKLIES, A.D., MORT, J.S., and POOLE, A.R. (1982). Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization. Cancer Res. 42, 1026-1032.
44. RUSSEL, M., KIDD, S., and KELLEY, M.R. (1986). Improved filamentous helper phage for generating single-stranded plasmid DNA. Gene 45, 333-338.
45. SALUJA, A., SALUJA, M., VILLA, A., LELI, U., RUTLEDGE, P., MELDOLESI, J., and STEER, M. (1989). Pancreatic duct obstruction in rabbits causes digestive zymogen and lysosomal colocalization. J. Clin. Invest. 84, 1260-1266.
46. SANGER, F., COULSON, A.R., BARRELL, B.G., SMITH, A.J.H., and ROE, B.A.J. (1980). Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J. Mol. Biol. 143, 161-178.
47. SHEAHAN, K., SHUJA, S., and MURNANE, M.J. (1989). Cysteine proteinase activities and tumor development in human colorectal carcinoma. Cancer Res. 49, 3809-3814.
48. SLOANE, B.F., HONN, K.V., SADLER, J.G., TURNER, W.A., KIMPSON, J.J., and TAYLOR, J.D. (1982). Cathepsin B activity in B16 melanoma cells: A possible marker for metastatic potential. Cancer Res. 42, 980-986.
49. SLOANE, B.F., ROZHIN, J., HATFIELD, J.S., CRISSMAN, J.D., and HONN, K.V. (1987). Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp. Cell. Biol. 55, 209-224.
50. SLOANE, B.F. (1990). Cathepsin B and cystatins: Evidence for a role in cancer progression. Semin. Cancer Biol. 1, 137-152.
51. WATANABE, M., HIGASHI, T., WATANABE, A., OSAWA, T., SATO, Y., KIMURA, Y., TOMINAGA, S., HASHIMOTO, N., YOSHIDA, Y., MORIMOTO, S., SHIOTA, T., HASHIMOTO, M., KOBAYASHI, M., TOMODA, J., and TSUJI, T. (1989). Cathepsin B and L activities in gastric cancer tissue: Correlation with histological findings. Biochem. Med. Met. Biol. 42, 21-29.
52. WEISS, R.E., LIU, B.C.-S., AHLERING, T., DUBEAU, L., and DROLLER, M.J. (1990). Mechanism of human bladder tumor invasion: Role of protease cathepsin B. J. Urol. 144, 798-804.
53. YOUNG, R.A., HAGENBUCHLE, O., and SCHIBLER, U. (1981). A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. Cell 23, 451-458.